Let refrigerated medication warm up
If you are breastfeeding or planning to breastfeed and considering GLP-1 therapy, this decision requires careful evaluation of your individual health context, lactation physiology, and infant risk factors
53 In both Phase 1a and 1b trials, it has been established that orforglipron does not have food or water administration restrictions and may provide a safe and effective oral treatment option for patients with T2D and other indications
The process cannot be rushed without sacrificing both comfort and long-term success
After a nearly two-year-long shortage, the US Food and Drug Administration (FDA) announced earlier this month that Eli Lillys GLP-1 diabetes drug Mounjaro (tirzepatide) is back on shelves along with weight loss version Zepbound
More serious but rare side effects include pancreatitis, kidney issues, allergic reactions, and possible thyroid tumors (seen in animal studies)